Veranstaltungsprogramm
Eine Übersicht aller Sessions/Sitzungen dieser Tagung.
Bitte wählen Sie einen Raum oder ein Datum aus, um nur die betreffenden Sitzungen anzuzeigen oder eine einzelne Sitzung um die gegebenenfalls vorhandenen Abstracts einsehen zu können.
|
Tagesübersicht | |
|
Raum: Hannover 170 |
| 10:30 - 12:00 |
Career Workshop: Raum: Hannover |
| 12:00 - 12:30 |
Presidents Opening Raum: Hannover Chair: Ioanna Gouni-Berthold Chair: Daniel Sedding Chair: Oliver Weingärtner |
| 12:30 - 14:00 |
Klinische Praxis - Von Risiko zu Therapie - Metabolik im Wandel Raum: Hannover Chair: Ulrich Laufs Chair: Stefan Lorkowski Adipositas: Aktuelle therapeutische Optionen als Weg zur Reduktion des CV Risikos Endokrinologikum Hamburg, Hamburg, Deutschland CV Risiko bei Typ 1 Diabetes und CV Prävention Universitätsklinikum Aachen RWTH Aachen, Aachen, Deutschland Inkretin-basierte Therapien Uniklinikum Aachen, Aachen, Deutschland |
| 14:15 - 15:00 |
Kardiovaskuläre Prävention - presented by Amgen Raum: Hannover Chair: Stephan Baldus Kardiovaskuläre Prävention – welche Möglichkeiten haben wir? Köln Elektive Bildgebung bei kardiovaskulären Hochrisikopatienten und was dann? University Hospital Cologne, Cologne, Deutschland Ergebnisse der VESALIUS-CV Studie Universitätsklinikum Köln (AöR), Köln, Deutschland Panel Diskussion - |
| 15:00 - 16:30 |
Young Investigator Session Raum: Hannover Chair: Norbert Gerdes Chair: Dennis Wolf ChemR23 in Macrophages: A Link Between PVAT Dysfunction and Vascular Inflammation in Atherosclerosis 1: Department of Vascular Surgery, Inselspital, Bern University Hospital, Bern, Switzerland; 2: Cardiovascular Research Cluster, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland; 3: Department of Angiology, Inselspital, Bern University Hospital, Bern, Switzerland; 4: Institute for Molecular Cardiovascular Research (IMCAR), RWTH University Hospital Aachen, Aachen, Germany; 5: Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University Munich (LMU), Munich, Germany; 6: DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany Hepatic CRISPR/dCas9-mediated overexpression of apolipoprotein A1 and paraoxonase 1 reduces the atherosclerotic burden in apoE deficient mice 1: Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, Bucharest, Romania; 2: Department of Pharmacology, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, 9112002, Jerusalem, Israel Short-term senolysis mitigates obesity-driven proarrhythmic cardiac remodeling 1: Division of Cardiology, Pulmonology and Vascular Medicine, Düsseldorf, Germany; 2: Institute of Cardiovascular Regeneration, Goethe University, Frankfurt am Main, Germany; 3: Cardiovascular Research Institute Düsseldorf, (CARID), Medical Faculty, Heinrich Heine University, Düsseldorf, Germany; 4: nstitute of Neuro- and Sensory Physiology, Medical Faculty, Heinrich-Heine University Düsseldorf, Germany The role of Fumarate hydratase 1 (FH1) in atherosclerosis 1: Uniklinik Köln, Köln, Deutschland; 2: Center of Cardiovascular Medicine (CCM ABCD) – Aachen, Bonn, Cologne, Düsseldorf; 3: Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; 4: University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute for Metabolomics in Ageing, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany; 5: Division of Biotherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Netherlands; 6: Institute of Experimental Hematology and Transfusion Medicine Bonn, Bonn, Germany; 7: Laboratory of Experimental Cardiology, Department of Cardiology, University Medical Center Utrecht, University Utrecht, Utrecht, Netherlands.; 8: Central Diagnostics Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands; 9: Amsterdam University Medical Centers, University of Amsterdam, Experimental Vascular Biology, Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences, Amsterdam Infection and Immunity, Amsterdam, the Netherlands; 10: University of Cologne, Faculty of Mathematics and Natural Sciences, Institute for Genetics, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany Comparison of high-sensitivity C-reactive protein and leukocyte-derived scores in prediction of cardiovascular risk in hospitalized patients 1: Department of Internal Medicine I — Cardiology, University Hospital Aachen, RWTH Aachen University, Aachen, Germany; 2: Department of Internal Medicine V — Pneumology, University Hospital Aachen, RWTH Aachen University, Aachen, Germany; 3: Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland; 4: RWTH cBMB at the Institute of Pathology, University Hospital Aachen, RWTH Aachen University, Germany GLP-1 levels predict adverse cardiovascular events in hospitalized patients with residual inflammatory risk 1: Department of Internal Medicine I — Cardiology, University Hospital Aachen, RWTH Aachen University, Aachen, Germany; 2: Department of Internal Medicine V — Pneumology, University Hospital Aachen, RWTH Aachen University, Aachen, Germany; 3: Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland; 4: RWTH cBMB at the Institute of Pathology, University Hospital Aachen, RWTH Aachen University, Germany |
| 16:45 - 17:30 |
ApoC3 Hemmung – von der Evolution zur Revolution bei schwerer Hypertriglyceridämie - presented by Sobi Raum: Hannover Chair: Ioanna Gouni-Berthold Evolution: ApoC3-Hemmung der nächsten Generation beim Familiären Chylomikronämie-Syndrom - ein Vergleich Universitätsklinikum Dresden, Dresden, Deutschland Revolution: Bedeutung der TG-reichen Lipoproteine für das kardiovaskuläre und Pankreatitis Risiko Universitätsklinikum Leipzig, Leipzig, Deutschland Dokumentation: CareHigh TG und die Genotyp-Phänotyp-Korrelation Synlab Holding Deutschland GmbH, Mannheim, Deutschland Evaluation: Erste Erfahrungen in Deutschland Universitätsklinikum Köln (AöR), Köln, Deutschland |
| 17:30 - 18:30 |
Awards Session Raum: Hannover Hauss Award: 1-phosphatidylinositol 3-phosphate 5-kinase inhibition by Apilimod promotes an adipocytelike vascular smooth muscle cell phenotype and prevents arterial calcification 1: Department of Internal Medicine I, Cardiology, University Hospital, Medical Faculty, RWTH Aachen, Aachen, Germany; 2: et al. |
| 9:00 - 10:30 |
Klinische Praxis - Personalisierte Medizin Raum: Hannover Chair: Ulrike Schatz Kardiovaskuläres Risiko Universitätsmedizin Mainz, Mainz, Deutschland Proteomics klinisch wichtig? Imperial College, London, Vereinigtes Königreich Lebensstilmaßnahmen - sinnvoll oder Quatsch Friedrich-Schiller-Universität Jena, Jena, Deutschland |
| 11:30 - 13:00 |
Basic Science (joint session ESC) - EVs and their Cargo Raum: Hannover Chair: Claudia Goettsch Chair: Karsten Grote The immune system’s involvement in atherosclerosis: Emphasising the significance of nanoparticles. Imperial College London, London, United Kingdom Extracellular Vesicle Subtypes for Cardiac Therapeutic Application University Medical Center, Utrecht, Netherlands, The Decoding Extracellular Vesicle Long Non-Coding RNAs as Master Regulators and Novel Therapeutics in Aortic Stenosis University Hospital Bonn, Molecular Cardiology, Heart Center, Bonn Senescent Adventitial Fibroblasts Drive IL-6–Dependent Endothelial Dysfunction in Diabetic Vasculature and Are Targetable by Senolysis 1: Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany; 2: et al. |
| 13:45 - 14:30 |
Atherosklerose: Prävention und Behandlung in Theorie und Praxis - presented by Daiichi Sankyo Raum: Hannover Chair: Ioanna Gouni-Berthold Was läuft schief in der Prävention und wie können wir es besser machen? Deutschen Herzzentrum München, München, Deutschland Das Update 2025 der ESC-Leitlinie Dyslipidämie: Umsetzung in der Versorgung von Hochrisikopatienten MVC CCB, Frankfurt |
| 14:30 - 16:00 |
Basic Science (joint session AG41 DGK) - Underlying mechanisms of modifiable risk factors Raum: Hannover Chair: Ingo Hilgendorf Chair: Hendrik Sager Innate immune training Radboudumc, Nijmegen, Netherlands, The Microbial Metabolites driving Atherosclerosis CNIC- Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain Amino acids: a healthy supplement or cardiovascular risk factors? Technical University of Munich, München, Deutschland |
| 16:15 - 17:00 |
Inflammation – from bench to bedside presented by Novo Nordisk Raum: Hannover Chair: Ingo Hilgendorf Targeting inflammation in atherosclerosis Universitätsklinikum Heidelberg, Heidelberg, Deutschland Colchicine – effects beyond the NLRP3 inflammasome Charité Berlin, Berlin, Deutschland Role of cardiovascular inflammation in clinical practice Universitätsklinikum Leipzig, Leipzig, Deutschland |
| 17:00 - 18:00 |
Keynote Raum: Hannover Chair: Ioanna Gouni-Berthold Metabolism om triglyceride-rich lipoproteins and their role in atherogenesis University of Gothenburg, Göteburg, Schweden |
| 9:00 - 10:30 |
Basic Science CVD comorbidities Raum: Hannover Chair: Yvonne Döring Chair: Michael Torzewski Diabetes and cardiovascular disease. Universitätsklinikum Aachen - RWTH Aachen, Aachen, Deutschland Targeting Early Innate Immune Cell Activation to Protect the Brain After Stroke 1: Institute for Experimental Immunology and Imaging, University of Duisburg-Essen, Esse, Germany; 2: University Hospital Essen, University of Duisburg-Essen, Essen, Germany, The aryl hydrocarbon receptor (AhR) is a novel regulator of lipid metabolism and atherosclerosis development. 1: Universitatsklinikum Aachen, Aachen, Deutschland; 2: IPEK, LMU München, Deutschland Ezh2 shapes T cell plasticity to drive atherosclerosis IPEK, LMU Klinikum, München, Deutschland |
| 11:00 - 12:30 |
Basic Science - Vascular disease and dissection Raum: Hannover Chair: Sabine Steffens Chair: Holger Winkels Translational therapeutic value of heterogenuous inflammatory acitvity in AAA Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Deutschland Exploration and modulation of innate immune responses in syndromic and non-syndromic aortopathy Universités-Praticien Hospitalier, Paris, Frankreich Nitrated fatty acids as a promising pharmacological treatment for abdominal aortic aneurysm 1: Universitätsklinik Köln, Köln, Deutschland; 2: Universität Bonn, Bonn, Deutschland; 3: Universität Düsseldorf, Düsseldorf, Deutschland; 4: Technische Universität Dresden, Dresden, Deutschland PI3 kinase-α-deficiency in vascular smooth muscle cells increases atherosclerosis and plaque instability. Uniklinik Köln, Köln, Deutschland |
| 12:30 - 13:00 |
Young Investigator Awards and Closing remarks Raum: Hannover |